Dartmouth Lead Participation in NCI National Clinical Trials Network
Dartmouth Lead Participation in NCI National Clinical Trials Network
批准号:
8839217
负责人:
Konstantin H. Dragnev
金额:
$31.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-16 至 2019-02-28
关键词:
AddressAdultAdvanced Malignant NeoplasmBackBasic ScienceCancer BiologyCancer PatientCancer and Leukemia Group BCaringCatchment AreaClinicalClinical OncologyClinical ResearchClinical TreatmentClinical TrialsClinical Trials Cooperative GroupCollaborationsComprehensive Cancer CenterConduct Clinical TrialsConsentCooperative Group ProgramDevelopmentDiagnosisDiagnosticDiseaseEducationEligibility DeterminationEngineeringEnrollmentEvaluationFundingFunding OpportunitiesFutureGeographic LocationsGoalsGynecologic Oncology GroupHealthImageImmunologyIndustryInstitutionInterdisciplinary StudyKnowledgeLaboratoriesLeadLeadershipLebanonMalignant NeoplasmsMedical centerMissionMonitorMulti-Institutional Clinical TrialNational Cancer InstituteNational Clinical Trials NetworkNew EnglandNew HampshireNorris Cotton Cancer CenterNursing ResearchOncology GroupPatient CarePatientsPhasePositioning AttributePreventivePrincipal InvestigatorProcessProtocols documentationRadiation Therapy Oncology GroupRandomizedRecording of previous eventsReportingRequest for ApplicationsResearchResearch InfrastructureResearch PersonnelResource SharingRuralSchoolsScienceScientistServicesSiteSystemTarget PopulationsTherapeuticTherapeutic TrialsTranslatingTranslational ResearchVermontanticancer researchbasecancer carecancer imagingcancer therapyclinical applicationcollegecommunity based practicedesigninnovationinterestmedical schoolsmedical specialtiesmedically underserved populationmembermultidisciplinarypatient populationphase III trialpreventprogramsresponsesymposiumtreatment trialtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Norris Cotton Cancer Center (NCCC), the keystone of the cancer-related activities of both Dartmouth College, and its Geisel School of Medicine, and Dartmouth-Hitchcock Health, will participate in the NCI's National Clinical Trials Network as a Lead Academic Participating Site. NCCC has a long history of leadership in national cooperative group clinical trials, dating back to serving as an operating center for CALGB, and more recently as a full member of CALGB's successor (the Alliance), RTOG, and COG, and as an Affiliate member of GOG. As the only NCI-designated Comprehensive Cancer Center in northern New England, NCCC currently serves annually over 5,200 new and 30,000 returning cancer patients. NCCC is the specialty academic center for Vermont and New Hampshire, anchoring a network of 17 community- based practice sites across the region and receiving referrals of rare and advanced cancers, the target population for enrollment on innovative clinical. Trials, from a large geographic catchment area. Within Dartmouth, NCCC has a central Office of Clinical Research (OCR) which coordinates full participation in the entire range of available clinical trials. NCCC intends to participate in all 6 pending NCI-designated networks, expanding its prior focus on participation in the Alliance. We anticipate earning annually close to
400 enrollment credits for adult subjects on studies, including a projected 74 consented subjects on interventional therapeutic trial s. Care at DH is organized into 17 designated interdisciplinary
disease-based teams which bring together all relevant specialties, 14 on a weekly basis, for new patient conferences at which eligibility for enrollment on clinical trials is assessed routinely. NCCC research nurses assigned to these Clinical Oncology Groups (COGs) are responsible for keeping the teams informed of available trials, and the NCCC clinical trials management system (Velos eResearch) provides the teams reports tracking current enrollment. While highest priority is given to translating NCCC science into clinical application, Dartmouth's size precludes most single-institution studies, and national cooperative group trials are prioritized ahead of industry
initiated studies for fulfillment of NCCC's clinical research mission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
“NCI National Clinical Trials Network - Network Lead Academic Participating Sites”
-
批准号:10734623
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Konstantin H. Dragnev
-
依托单位:
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
-
批准号:10116977
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2019
-
负责人:Konstantin H. Dragnev
-
依托单位:
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
-
批准号:10357862
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2019
-
负责人:Konstantin H. Dragnev
-
依托单位:
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
-
批准号:9894768
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2019
-
负责人:Konstantin H. Dragnev
-
依托单位:
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
-
批准号:10581527
-
项目类别:
-
资助金额:$43.44万
-
财政年份:2019
-
负责人:Konstantin H. Dragnev
-
依托单位:
Dartmouth Lead Participation in NCI National Clinical Trials Network
-
批准号:8605705
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2014
-
负责人:Konstantin H. Dragnev
-
依托单位:
Clinical Protocol and Data Management (CPDM)
-
批准号:10311240
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1997
-
负责人:Konstantin H. Dragnev
-
依托单位:
Clinical Protocol and Data Management (CPDM)
-
批准号:10554300
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1997
-
负责人:Konstantin H. Dragnev
-
依托单位:
Clinical Protocol and Data Management (CPDM)
-
批准号:10165525
-
项目类别:
-
资助金额:$24.36万
-
财政年份:--
-
负责人:Konstantin H. Dragnev
-
依托单位:
海外基金